Security key
45826J105
Intellia Therapeutics, Inc. - COMMON STOCK (NTLA)
CUSIP: 45826J105
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 56,492,124
- Total 13F value
- $1,125,276,243
- Share change
- +2,551,785
- Put/Call ratio
- 60%
- SEC-reported price per share
- $19.88
- Number of holders
- 161
- Value change
- +$49,648,218
- Number of buys
- 89
- Number of sells
- 57
- Shares outstanding
- 135,808,632
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
161
Top holders
10
NTLA full security history
Ownership snapshot
Full 13F holder table
Intellia Therapeutics, Inc. SEC filings
Intellia Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NTLA - Intellia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F
Highest disclosed value: $239,699,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC has the largest disclosed position value at $239.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Disclosed position value
Top 5
ARK Investment Management LLC
$239.7M
Sumitomo Mitsui Trust Group, Inc.
$130.22M
Amova Asset Management Americas, ...
$123.67M
BlackRock Finance, Inc.
$106.17M
VANGUARD GROUP INC
$89.49M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
—
denominator unverified
|
$239,699,000
11,403,379 shares
|
— | 30 Jun 2020 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
—
denominator unverified
|
$130,223,000
6,195,189 shares
|
— | 30 Jun 2020 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
—
denominator unverified
|
$123,671,000
6,183,547 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$106,168,000
5,050,826 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$89,486,000
4,257,196 shares
|
— | 30 Jun 2020 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$48,751,000
2,319,288 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
161
Shares
56,492,124
Rows available
161
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
160
Q3 2020 holders
161
Holder diff
1
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|